Skip to content
10-Q

Quarterly Report

THC THERAPEUTICS, INC.

0001477932-24-000083

← back to feed
Filed
Jan 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Dec 22, 2023 34.21M sh
Stock Repurchased Q3 2023 · Apr 30, 2023 $0
Stock Repurchased Q3 2023 · Apr 30, 2022 $97.5K
Cash And Equivalents Q3 2023 · Apr 30, 2023 $15
Cash And Equivalents Q3 2023 · Jul 31, 2022 $32
Current Liabilities Q3 2023 · Apr 30, 2023 $3.19M
Current Liabilities Q3 2023 · Jul 31, 2022 $3.22M
Total Liabilities Q3 2023 · Apr 30, 2023 $3.19M
Total Liabilities Q3 2023 · Jul 31, 2022 $3.22M
Current Assets Q3 2023 · Apr 30, 2023 $985
Current Assets Q3 2023 · Jul 31, 2022 $40.71K
Total Assets Q3 2023 · Apr 30, 2023 $13.35K
Total Assets Q3 2023 · Jul 31, 2022 $206.9K
Sga Expense Q3 2023 · Apr 30, 2023 $3.42K
Sga Expense Q3 2023 · Apr 30, 2023 $69.24K
Sga Expense Q3 2023 · Apr 30, 2022 $33.44K
Sga Expense Q3 2023 · Apr 30, 2022 $148.61K
Operating Cash Flow Q3 2023 · Apr 30, 2022 −$395.36K
Stockholders Equity Q3 2023 · Apr 30, 2022 −$3.86M
Stockholders Equity Q3 2023 · Jan 31, 2022 −$3.23M
Stockholders Equity Q3 2023 · Oct 31, 2021 −$2.93M
Stockholders Equity Q3 2023 · Jul 31, 2021 −$2.48M
Net Income Q3 2023 · Apr 30, 2022 −$632.28K
Net Income Q3 2023 · Jan 31, 2022 −$752.46K
Net Income Q3 2023 · Oct 31, 2021 −$486.44K
Operating Income Q3 2023 · Apr 30, 2022 −$123.53K
Operating Income Q3 2023 · Apr 30, 2022 −$1.21M
Gross Profit Q3 2023 · Apr 30, 2022 $0
Gross Profit Q3 2023 · Apr 30, 2022 $0
Cost Of Revenue Q3 2023 · Apr 30, 2022 $0
Cost Of Revenue Q3 2023 · Apr 30, 2022 $0
Revenue Q3 2023 · Apr 30, 2022 $0
Revenue Q3 2023 · Apr 30, 2022 $0